Buccal vs Sublingual Mucosa: Why the Delivery Sites Behave Differently

Buccal and sublingual mucosa behave differently in peptide film research because the two sites differ in epithelial thickness, permeability, tissue architecture, salivary exposure, mechanical movement, available surface area, and suitability for prolonged film retention. Sublingual mucosa is generally thinner and more permeable, while buccal mucosa provides a thicker, comparatively stable surface that can better support mucoadhesive residence. These differences mean a film tested at one site cannot automatically be assigned the exposure profile measured at the other.

The distinction between the cheek and floor of the mouth is fundamental to oromucosal peptide film research. Both sites are non-keratinized regions commonly investigated for drug delivery, but their structural and environmental differences change the balance among film retention, peptide release, dilution, and tissue transport.

Research-use notice for comparisons of buccal versus sublingual mucosa in peptide film studies: InStrips products are supplied for research and analytical investigation of oral-mucosal anatomy, film behavior, peptide permeation, residence time, and related site-specific delivery variables. Buccal and sublingual research findings are not intended to diagnose, treat, cure, prevent, or manage any disease, injury, deficiency, absorption disorder, digestive condition, or other medical condition.

The most important experimental lesson is that “oromucosal” does not identify one uniform membrane. A result obtained from buccal tissue belongs to a different anatomical environment from a result generated beneath the tongue.

The Buccal Site Is the Inner Cheek

Buccal mucosa lines the inside of the cheek.

It provides:

• a relatively broad mucosal area
• a comparatively stable placement surface
• non-keratinized epithelium
• potential for prolonged mucoadhesion

These characteristics influence the types of films commonly investigated at this site.

The Sublingual Site Is the Floor of the Mouth

Sublingual mucosa occupies the region beneath the tongue.

It is characterized by:

• relatively thin epithelium
• high permeability relative to buccal mucosa
• substantial vascularization
• greater exposure to pooled saliva
• continuous tongue movement

Both Sites Are Non-Keratinized, but They Are Not Equivalent

Non-keratinized epithelium generally presents a different barrier from the more strongly keratinized tissues of the hard palate and gingiva.

However, even within the non-keratinized category, buccal and sublingual tissues differ substantially.

Epithelial Thickness Is One of the Clearest Differences

Buccal epithelium is commonly reported at approximately:

• 500 to 800 micrometers

while sublingual epithelium is often described at approximately:

• 100 to 200 micrometers

Values vary with tissue source and measurement method, but the directional difference is substantial.

A Thicker Barrier Creates a Longer Diffusion Path

For passive diffusion, the distance a molecule must cross can influence transport rate.

All else being equal, a longer path can reduce flux.

Biological membranes are more complicated than a uniform sheet, so thickness should be considered alongside composition and molecular properties.

Sublingual Mucosa Is Generally More Permeable

The combination of thinner epithelium and site-specific tissue structure contributes to greater sublingual permeability for many compounds.

This helps explain why sublingual dosage forms have often been investigated for:

• relatively rapid absorption

rather than prolonged release.

Buccal Mucosa Offers a More Substantial Barrier

Buccal transport can be slower because of:

• greater epithelial thickness
• barrier organization
• peptide size and polarity

This can make prolonged contact especially important.

Permeability and Residence Time Can Work in Opposite Directions

The site with higher intrinsic permeability may have less stable dosage-form retention.

The site with lower permeability may allow longer contact.

This creates an important formulation tradeoff:

• rapid transport through a dynamic site
• slower transport over a longer contact period

Buccal Films Can Be Designed for Longer Residence

The inner cheek can support formulations emphasizing:

• mucoadhesion
• controlled hydration
• extended peptide release
• localized placement

This does not mean all buccal films must be slow release.

Sublingual Films Often Emphasize Faster Release

The floor-of-mouth environment can favor formulations designed to:

• wet quickly
• disintegrate relatively quickly
• release the payload rapidly

because prolonged residence can be more difficult.

Saliva Does Not Affect the Two Sites in Exactly the Same Way

Both buccal and sublingual films encounter saliva.

However, fluid can accumulate beneath the tongue and interact strongly with sublingual formulations.

This can accelerate:

• hydration
• dissolution
• drug redistribution

Rapid Hydration Has Both Advantages and Limitations

Water entering a film is necessary to mobilize peptide.

Too little hydration can slow release.

Very rapid hydration can contribute to:

• rapid dissolution
• loss of localization
• dilution into the oral cavity

Salivary Washout Can Reduce Local Exposure

Once peptide is dissolved, movement of saliva can carry it away from the application site.

This reduces the amount of time during which a high local concentration exists immediately adjacent to the mucosa.

Mucoadhesion Helps Counter Washout

Mucoadhesive polymers can help keep the formulation in contact with tissue.

The strength required may differ by site because of differences in:

• fluid movement
• mucosal motion
• intended residence time

The Tongue Creates a Distinct Mechanical Environment Sublingually

Sublingual films are exposed to movement from:

• speech
• swallowing
• tongue repositioning

These forces can affect film location and integrity.

Buccal Tissue Is Mechanically Dynamic Too

The cheek moves during:

• speech
• chewing
• facial expression

but the placement environment differs from the tongue-floor interface.

Available Surface Area Differs

Buccal mucosa provides a relatively large region for film placement.

The sublingual space is more constrained.

This can affect:

• film dimensions
• peptide loading per unit area
• comfort-related design
• total contact area

Larger Surface Area Does Not Automatically Mean Greater Exposure

Exposure also depends on:

• permeability
• concentration gradient
• residence time
• film release

A smaller but more permeable site can behave differently from a larger but less permeable one.

Blood Supply Is Relevant to In Vivo Uptake

Both buccal and sublingual tissues have underlying vascular networks.

Once a molecule has crossed the epithelial barrier, local blood flow can influence removal from the tissue and maintenance of a concentration gradient.

Ex Vivo Permeability Does Not Include Normal Blood Flow

A diffusion cell replaces physiological clearance with:

• a receptor solution

and controlled mixing.

This provides standardized transport data but does not recreate living microcirculation.

Tissue Lipids Contribute to Barrier Properties

Epithelial permeability is influenced not only by cell number but also by intercellular components and lipid organization.

For peptide molecules, these structural characteristics can strongly limit passive diffusion.

Peptide Transport Is Especially Sensitive to Barrier Differences

Peptides commonly have properties that complicate mucosal transport, including:

• relatively high molecular weight
• multiple hydrogen-bonding groups
• charge
• limited membrane partitioning

A modest anatomical difference can therefore become important for measured flux.

The Same Peptide Can Produce Different Flux at the Two Sites

If formulation, peptide concentration, and temperature are held constant, buccal and sublingual tissues can still produce different:

• lag time
• flux
• tissue retention

because the membranes themselves differ.

That Does Not Make One Site Universally Better

A higher permeability value does not automatically make the sublingual route superior for every film.

The optimal experimental site also depends on:

• desired release rate
• required residence time
• peptide stability
• dose
• formulation architecture

Film Design Can Be Site Specific

A buccal formulation might emphasize:

• stronger adhesion
• slower erosion
• directional release

A sublingual formulation might emphasize:

• rapid wetting
• fast release
• small film size

Testing one formulation at both sites without optimization can therefore produce misleading comparisons.

Backing Layers Are More Natural for Some Buccal Designs

A unidirectional buccal film can include an impermeable or relatively impermeable backing.

This can reduce release into saliva and favor contact with:

• the mucosal surface

The same physical architecture may be less convenient under the tongue depending on design.

Dose Loading Per Area Can Differ

If the film area is smaller, the formulation may need greater peptide loading per unit area to provide the same nominal dose.

This can change:

• film thickness
• crystallization risk
• release kinetics
• mechanical properties

Local pH Can Differ From Bulk Measurements

The microenvironment between film and mucosa can be influenced by:

• film excipients
• saliva
• buffering capacity
• peptide ionization

Site-specific fluid dynamics can therefore change local pH behavior.

Enzyme Exposure May Also Differ

Peptide stability can be influenced by:

• salivary enzymes
• mucosal peptidases
• exposure duration

A longer buccal residence time can mean more prolonged enzymatic exposure even if fluid washout is slower.

Permeation Enhancers May Behave Differently at Each Site

An enhancer studied with buccal tissue should not automatically be expected to produce the same result sublingually.

Differences may occur in:

• baseline permeability
• enhancer penetration
• tissue interaction
• absolute flux

Matched Comparative Experiments Are More Informative

A strong buccal-versus-sublingual experiment holds constant variables such as:

• peptide concentration
• film formulation
• temperature
• receiver medium
• sampling schedule

while changing only the mucosal site where possible.

Species and Site Need to Be Reported Together

“Porcine oral mucosa” is not sufficiently precise for a site-specific comparison.

Researchers should ideally state:

• species
• buccal or sublingual region
• tissue preparation method

Tissue Thickness Can Be Measured Rather Than Assumed

Histological sections or other dimensional methods can quantify the barrier used in a particular experiment.

This is useful because published average thickness values may not match the exact specimen being tested.

Permeability Should Be Normalized Carefully

Researchers may report transport as:

• cumulative amount
• amount per unit area
• flux
• permeability coefficient

Comparing raw amounts from films with different contact areas can be misleading.

Buccal and Sublingual Human Pharmacokinetics Are Not Interchangeable Either

Even if two formulations contain the same nominal peptide dose, site-specific differences can alter:

• rate of absorption
• time to peak concentration
• total exposure
• variability

Each route condition should be measured directly.

“Oromucosal Bioavailability” Can Hide the Actual Site

A paper may use a broad route label even when the dosage form was placed:

• against the cheek
• under the tongue
• elsewhere in the oral cavity

The exact placement should be identified before comparing studies.

The Buccal Research Model Shows the Retention Side of the Comparison

Mucoadhesion, controlled release, and a comparatively stable application area are particularly important in research on buccal peptide film delivery.

Research Notes: Route Labels Should Be Treated as Experimental Variables

“Buccal,” “sublingual,” and “oromucosal” should not be used as interchangeable labels when comparing peptide-film studies. The anatomical site changes the barrier itself, the fluid environment surrounding the film, and the amount of time the formulation can remain localized.

For that reason, a useful comparison starts by recording exactly where the film was placed and what tissue was used in permeability experiments. Only then does it make sense to compare release, flux, concentration-time profiles, or apparent bioavailability.

External Anatomical and Permeability Evidence

The review Transmucosal Drug Administration as an Alternative Route in Palliative and End-of-Life Care During the COVID-19 Pandemic summarizes structural differences between oral regions, including buccal epithelium at roughly 500 to 800 micrometers and sublingual epithelium at roughly 100 to 200 micrometers, with the thinner sublingual tissue showing greater permeability.

What Buccal-versus-Sublingual Research Can Establish

Matched experiments may establish differences in:

• epithelial thickness
• mucosal permeability
• film residence
• salivary exposure
• peptide flux
• tissue retention

What Anatomical Differences Do Not Establish Automatically

They do not independently establish:

• which site is optimal for every peptide
• identical performance across formulations
• human bioavailability
• equivalent dosing between routes
• a clinical outcome

Final Perspective

Buccal and sublingual mucosa behave differently because they are different biological and mechanical environments, not merely two names for oral placement.

Sublingual tissue is thinner and generally more permeable, while buccal tissue provides a thicker barrier but a comparatively stable surface for mucoadhesive film residence. Saliva, movement, contact area, film design, and peptide properties further widen the difference.

For peptide-film research, this means exposure data should remain site specific. A buccal film result belongs to the cheek environment, and a sublingual result belongs to the floor-of-mouth environment unless a direct comparative study demonstrates otherwise.